![Debora Marks](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Debora Marks
Corporate Officer/Principal bij Institute For Protein Innovation, Inc.
Actieve functies van Debora Marks
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Institute For Protein Innovation, Inc.
![]() Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022. | Corporate Officer/Principal | - | - |
Loopbaan van Debora Marks
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Corporate Officer/Principal | 1 |
Sectoraal
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Institute For Protein Innovation, Inc.
![]() Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022. | Commercial Services |
- Beurs
- Insiders
- Debora Marks
- Ervaring